Diabetes Drug Prevention or Kidney Disease Slow

A new study showed that the canagliflozin diabetes drug (Invokana, Janssen) could help prevent or relieve kidney disease, t The Press reported. According to the article, the researchers assessed 13,000 people with type 2 diabetes and chronic kidney disease who were given canagliflozin or placebo. Overall, those who had canagliflozin had a lower 30% risk of kidney failure, the need for dialysis, the need for kidney transplantation, death from kidney or heart causes, or symptoms. other kidney failure.

About half of patients with cancer have insomnia symptoms, t Reuters reported. According to the article, a recent study examined data on 405 cancer patients and completed 2 insomnia intensity assessments, once they came into the study and again 12 months later. At the start of the study, 49% of patients had insomnia symptoms and 64% of patients who started with insomnia continued to experience symptoms after one year.

The data showed that the Ebola experimental vaccine being used to cover the outbreak in the Democratic Republic of Congo is protected by 97.5% of the time, STAT reported. According to the article, more than 90,000 people have been vaccinated, only 71 have developed Ebola and 56 of these have developed signs less than 10 days after being vaccinated. In addition, only 15 individuals developed Ebola more than 10 days after being vaccinated, the article was reported.


Leave a comment

Send a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.